Use of nonsteroidal anti-inflammatory drugs and risk of ovarian and endometrial cancer: the Multiethnic Cohort.

Abstract

BACKGROUND:

Chronic inflammation may play an etiologic role in ovarian and endometrial cancer, and it is hypothesized that nonsteroidal anti-inflammatory drugs (NSAID) decrease the risk of developing these malignancies. No prospective study with a large multiethnic population has explored this hypothesis.

METHODS:

We investigated whether NSAID use was associated with risks of ovarian and endometrial cancer in the Multiethnic Cohort Study. Medication use of at least twice a week for ≥1 month was assessed at baseline. Multivariable relative risks (RR) and 95% confidence intervals (CI) were estimated using Cox proportional hazards models.

RESULTS:

During 13.3 years of follow-up, 275 ovarian and 620 endometrial incident cases were identified among approximately 64,000 women included in this analysis (16.5% African Americans, 30.8% Japanese, 7.7% Native Hawaiians, 18.9%, Latinas, and 26.0% whites). The RR (95% CI) for ovarian cancer associated with aspirin, non-aspirin NSAIDs, and acetaminophen were 0.87 (0.68-1.14), 0.97 (0.74-1.26), and 0.86 (0.67-1.12), respectively. The RR (95% CI) for endometrial cancer associated with aspirin, non-aspirin NSAIDs, and acetaminophen were 0.93 (0.79-1.10), 0.88 (0.74-1.05), and 0.96 (0.81-1.13), respectively. No heterogeneity across ethnic groups (P ≥ 0.29) or dose-response relation with increased duration of use (P(trend) ≥ 0.16) was observed. The results did not differ by tumor histology.

CONCLUSIONS:

We found no compelling evidence to support an association between the use of NSAIDs and risk of ovarian and endometrial cancers in a multiethnic population.

IMPACT:

It is unlikely that NSAID is involved in the etiology of endometrial and ovarian cancer.

• Authors: Veronica Wendy Setiawan, Rayna K Matsuno, Galina Lurie, Lynne R Wilkens, Michael E Carney, Brian E Henderson, Laurence N Kolonel, Marc T Goodman
• Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (Cancer Epidemiol Biomarkers Prev) Vol. 21 Issue 9 Pg. 1441-9 (Sep 2012) ISSN: 1538-7755 [Electronic] United States
• PMID: 22665579 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
• Copyright: ©2012 AACR

Chemical References

• Anti-Inflammatory Agents, Non-Steroidal

Topics

• Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
• Cohort Studies
• Endometrial Neoplasms (ethnology, prevention & control)
• Female
• Humans
• Middle Aged
• Ovarian Neoplasms (ethnology, prevention & control)
• Prospective Studies
• Risk